Mitsubishi UFJ Trust & Banking Corp Sells 35,560 Shares of Doximity, Inc. (NASDAQ:DOCS)

Mitsubishi UFJ Trust & Banking Corp reduced its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 11.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 271,281 shares of the company’s stock after selling 35,560 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned about 0.15% of Doximity worth $14,484,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Global Retirement Partners LLC increased its holdings in Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after acquiring an additional 440 shares during the last quarter. UMB Bank n.a. boosted its position in Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after purchasing an additional 235 shares during the period. Larson Financial Group LLC increased its stake in shares of Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock worth $40,000 after purchasing an additional 250 shares in the last quarter. Optimum Investment Advisors bought a new stake in shares of Doximity in the fourth quarter valued at approximately $43,000. Finally, Morse Asset Management Inc bought a new position in Doximity in the 3rd quarter worth approximately $46,000. 87.19% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. Leerink Partners upgraded Doximity from a “market perform” rating to an “outperform” rating and increased their target price for the stock from $60.00 to $90.00 in a research report on Friday, February 7th. Wells Fargo & Company restated an “equal weight” rating on shares of Doximity in a research note on Friday, February 7th. KeyCorp decreased their price target on Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 8th. Bank of America raised their price objective on shares of Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research report on Monday, January 6th. Finally, Raymond James reaffirmed an “outperform” rating and set a $83.00 target price (up previously from $65.00) on shares of Doximity in a report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $64.22.

Insider Buying and Selling at Doximity

In other news, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 37.40% of the company’s stock.

Doximity Trading Down 3.6 %

Shares of Doximity stock opened at $58.40 on Friday. The business’s 50-day moving average price is $65.48 and its 200-day moving average price is $54.30. The firm has a market capitalization of $10.90 billion, a PE ratio of 58.40, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.